Stocks and InvestingStocks and Investing
Mon, November 29, 2021
Fri, November 26, 2021
Wed, November 24, 2021
Tue, November 23, 2021
Mon, November 22, 2021

Luca Issi Upgraded (ALNY) to Buy and Increased Target to $225 on, Nov 22nd, 2021


Published on 2024-10-27 18:45:03 - WOPRAI, Luca Issi
  Print publication without navigation


Luca Issi of RBC Capital, Upgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Buy and Increased Target from $144 to $225 on, Nov 22nd, 2021.

Luca has made no other calls on ALNY in the last 4 months.



There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 3 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $108 on, Thursday, October 28th, 2021
  • Gary Nachman of "BMO Capital" Maintained at Hold with Increased Target to $196 on, Friday, August 27th, 2021
  • Edward Tenthoff of "Piper Sandler" Downgraded from Buy to Hold and Held Target at $181 on, Wednesday, August 4th, 2021


These are the ratings of the 7 analyists that currently disagree with Luca


  • Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $200 on, Monday, November 1st, 2021
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $200 on, Friday, October 29th, 2021
  • David Lebowitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $226 on, Friday, October 29th, 2021
  • Esther Rajavelu of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $215 on, Monday, October 4th, 2021
  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $250 on, Friday, August 13th, 2021
  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $234 on, Wednesday, August 4th, 2021
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $216 on, Wednesday, August 4th, 2021